These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25183612)

  • 21. Current oral antiplatelets: focus update on prasugrel.
    John J; Koshy SK
    J Am Board Fam Med; 2012; 25(3):343-9. PubMed ID: 22570398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual thienopyridine low-response to clopidogrel and prasugrel in a patient with STEMI, cardiogenic shock and early stent thrombosis is overcome by ticagrelor.
    Orban M; Riegger J; Joner M; Tada T; Okrojek R; Hausleiter J; Kastrati A; Massberg S; Sibbing D
    Platelets; 2012; 23(5):395-8. PubMed ID: 22671583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials.
    James SK; Pieper KS; Cannon CP; Storey RF; Becker RC; Steg PG; Wallentin L; Harrington RA;
    Stroke; 2013 May; 44(5):1477-9. PubMed ID: 23572474
    [No Abstract]   [Full Text] [Related]  

  • 24. Current Evidence on Platelet P2Y12 Receptor Inhibitors: Is There Still a Role for Clopidogrel in 2015?
    Qutub MA; Chong AY; So DY
    Can J Cardiol; 2015 Dec; 31(12):1481-4. PubMed ID: 26243350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prasugrel as antiplatelet therapy in patients with acute coronary syndromes or undergoing percutaneous coronary intervention.
    Fletcher B; Thalinger KK
    Crit Care Nurse; 2010 Oct; 30(5):45-54. PubMed ID: 20889512
    [No Abstract]   [Full Text] [Related]  

  • 26. Predictors of bleeding in acute coronary syndromes with clopidogrel and prasugrel.
    Rodriguez L; Conde D; Lalor N; Elissamburu P; Trivi M
    Am J Emerg Med; 2013 Aug; 31(8):1287. PubMed ID: 23769852
    [No Abstract]   [Full Text] [Related]  

  • 27. Platelet inhibition by abciximab bolus-only administration and oral ADP receptor antagonist loading in acute coronary syndrome patients: the blocking and bridging strategy.
    Christ G; Hafner T; Siller-Matula JM; Francesconi M; Grohs K; Wilhelm E; Podczeck-Schweighofer A
    Thromb Res; 2013 Jul; 132(1):e36-41. PubMed ID: 23791395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New approaches and indications for the analysis of platelet function in cardiology].
    Ivandic B; Frey N
    Hamostaseologie; 2011 May; 31(2):73-6. PubMed ID: 21152679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clopidogrel in coronary artery disease: update 2012.
    Huber K
    Adv Cardiol; 2012; 47():31-8. PubMed ID: 22906901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Dasbiswas A; Rao MS; Babu PR; Vijayvergiya R; Nayak R; Dani S; Tyagi S; Hiremath S; Patel T; Alexander T; Prakash VS; Singh DP; Yadav MK; Pathak K; Srivastava A
    J Assoc Physicians India; 2013 Feb; 61(2):114-6, 126. PubMed ID: 24471250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prasugrel for the treatment of coronary thrombosis: a review of pharmacological properties, indications for use and future development.
    Tomasello SD; Tello-Montoliu A; Angiolillo DJ
    Expert Opin Investig Drugs; 2011 Jan; 20(1):119-33. PubMed ID: 21143003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of comparative treatment effects using indirect comparisons.
    Catalá-López F
    Rev Esp Cardiol (Engl Ed); 2013 Feb; 66(2):156-7. PubMed ID: 24775399
    [No Abstract]   [Full Text] [Related]  

  • 33. Advances in antiplatelet therapy for acute coronary syndromes.
    Contractor H; Ruparelia N
    Postgrad Med J; 2012 Jul; 88(1041):391-6. PubMed ID: 22357775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of comparative treatment effects using indirect comparisons. Response.
    Marrugat J; Vila J; Elosua R
    Rev Esp Cardiol (Engl Ed); 2013 Feb; 66(2):157. PubMed ID: 24775400
    [No Abstract]   [Full Text] [Related]  

  • 35. Ticagrelor (Brilinta)--better than clopidogrel (Plavix)?
    Med Lett Drugs Ther; 2011 Sep; 53(1372):69-70. PubMed ID: 21897348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antithrombotic treatment in acute coronary syndrome].
    Darius H; Rupprecht HJ; Genth-Zotz S; Wittlinger T; Zotz R
    Dtsch Med Wochenschr; 2014 Jan; 139 Suppl 1():S17-22. PubMed ID: 24446037
    [No Abstract]   [Full Text] [Related]  

  • 37. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
    Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ticagrelor approved for acute coronary syndrome.
    Traynor K
    Am J Health Syst Pharm; 2011 Sep; 68(17):1568. PubMed ID: 21856798
    [No Abstract]   [Full Text] [Related]  

  • 39. Ticagrelor--is there need for a new player in the antiplatelet-therapy field?
    Schömig A
    N Engl J Med; 2009 Sep; 361(11):1108-11. PubMed ID: 19717845
    [No Abstract]   [Full Text] [Related]  

  • 40. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.